Home » Topics » Regulatory

Regulatory
RSS

European approvals for RPR's Nasacort AQ

Nov. 28, 1997

Antileukemic effects described for vesnarinone

Nov. 28, 1997

Immunex seeks FDA approval for generic paclitaxel injection

Nov. 28, 1997

First anticancer monoclonal antibody approved by FDA

Nov. 27, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

Forest files for FDA approval of Synapton

Nov. 26, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

Extended-release Effexor introduced in U.S. for depression

Nov. 26, 1997

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

Nov. 25, 1997

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...